Earnings (Loss) per Share

6 Months Ended

Jun. 30, 2026

Basic and diluted earnings (loss) per share for the three and six months ended June 30, 2026 and 2025, respectively, consisted of the following (in thousands, except per share data):


	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Numerator (Basic and Diluted):
Net income (loss)	$	3,909	$	(11,035)	$	809	$	(15,457)
Change in value for stock settled consideration(1)	—		—		—		5
Adjusted net income (loss)	$	3,909	$	(11,035)	$	809	$	(15,452)

Denominator:
Basic
Weighted average common shares issued and outstanding	37,845		39,021		38,031		38,984
Deduct: Unvested RSAs(2)	(18)		(17)		(18)		(17)
Weighted average common shares outstanding	37,827		39,004		38,013		38,967

Basic earnings (loss) per common share	$	0.10	$	(0.28)	$	0.02	$	(0.40)
Diluted
Weighted average common shares outstanding from above	37,827		39,004		38,013		38,967
Add: Dilutive effect of RSUs, RSAs, PSUs & ESPP(3)	192		—		236		—
Weighted average common shares outstanding	38,019		39,004		38,249		38,967
Diluted earnings (loss) per common share	$	0.10	$	(0.28)	$	0.02	$	(0.40)
Antidilutive shares excluded from diluted earnings (loss) per common share(4)	706		1,297		847		1,184

(1)Relates to contingently issuable stock settled consideration.

(2)RSAs were issued to the non-employee directors and will vest in full on the earlier of the first anniversary of the date of grant or the next annual meeting of stockholders, subject to service requirements. See Note 9 – “Stock-Based Compensation Plans” for additional information.

(3)Shares related to the Company's RSUs, RSAs, PSUs, Amended ESPP, and contingently issuable shares were excluded from the weighted average common shares outstanding for the three and six months ended June 30, 2025 because inclusion of such shares would be antidilutive in a period of loss.

(4)Primarily pertaining to RSU grants to the Company’s employees and independent contractors.